Differential Expression of Vascular Endothelial Growth Factor in Glucocorticoid-related Osteonecrosis of the Femoral Head

VEGF plays a role in bone remodeling. Ingrowth of reparative arterioles can be observed in late-stage osteonecrosis. To explore the reparative processes, we quantified the most important angiogenesis factor (VEGF) in different zones of late-stage glucocorticoid-induced osteonecrosis. We treated prim...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical orthopaedics and related research 2009-12, Vol.467 (12), p.3273-3282
Hauptverfasser: Varoga, Deike, Drescher, Wolf, Pufe, Melanie, Groth, Godo, Pufe, Thomas
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3282
container_issue 12
container_start_page 3273
container_title Clinical orthopaedics and related research
container_volume 467
creator Varoga, Deike
Drescher, Wolf
Pufe, Melanie
Groth, Godo
Pufe, Thomas
description VEGF plays a role in bone remodeling. Ingrowth of reparative arterioles can be observed in late-stage osteonecrosis. To explore the reparative processes, we quantified the most important angiogenesis factor (VEGF) in different zones of late-stage glucocorticoid-induced osteonecrosis. We treated primary nonosteonecrosis osteoblasts with glucocorticoids in vitro as a model for the bone cells in early-stage steroid-related osteonecrosis. We obtained six late-stage (ARCO Stage IV) osteonecrosis femoral heads and six osteoarthritic femoral heads during THA. The expression of vascular endothelial growth factor was analyzed by reverse-transcription PCR, ELISA, or immunohistochemistry. Osteoblasts from the reactive interface (penumbra) of osteonecrosis femoral heads exhibited increased immunoreactivity to VEGF compared to those from the periphery. ELISA confirmed VEGF upregulation in the penumbra from osteonecrosis femoral heads. Primary osteoblasts derived from osteoarthritic femoral heads exhibited downregulation of VEGF after 24 hours of coincubation with glucocorticoids. The increase in VEGF in the reactive interface (penumbra) of osteonecrosis in late-stage femoral head may reflect a secondary phenomenon. The observed high amount of VEGF in later-stage osteonecrosis might stimulate the ingrowth of reparative arterioles into the femoral head.
doi_str_mv 10.1007/s11999-009-1076-3
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2772917</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2027497541</sourcerecordid><originalsourceid>FETCH-LOGICAL-c534t-1ef6326a4358186fe4022037e62afd0d6865138fa05e1fa73e2323cfec38f20b3</originalsourceid><addsrcrecordid>eNp1kUFv1DAQhS1U1C6FH8ClsnoP2J7ETi6VUNndIlXqBareLNcZd11l48V2Cv33ONpVCwdO1vi9-WZGj5CPnH3ijKnPifOu6yrGuoozJSt4Qxa8EW3FOYgjsmCz0gl-d0LepfRYSqgbcUxOeKckKFEvyPNX7xxGHLM3A13-3kVMyYeRBkdvTbLTYCJdjn3IGxxmyzqGX3lDV8bmEKkf6XqYbLAhZm-D76uIg8nY05uUMYxoY0g-zbQCoCvchlggV2j69-StM0PCD4f3lPxYLb9fXlXXN-tvl1-uK9tAnSuOToKQpoam5a10WDMhGCiUwrie9bKVDYfWGdYgd0YBChBgHdryKdg9nJKLPXc33W-xt-XUsoLeRb818VkH4_W_yug3-iE8aaGU6LgqgPMDIIafE6asH8MUx7KzFgCyqUGKYuJ703xwiuheBnCm57D0PixdItFzWBpKz9nfm712HNIpBrE3pCKNDxhfJ_-f-geWmaJB</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>233654362</pqid></control><display><type>article</type><title>Differential Expression of Vascular Endothelial Growth Factor in Glucocorticoid-related Osteonecrosis of the Femoral Head</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Varoga, Deike ; Drescher, Wolf ; Pufe, Melanie ; Groth, Godo ; Pufe, Thomas</creator><creatorcontrib>Varoga, Deike ; Drescher, Wolf ; Pufe, Melanie ; Groth, Godo ; Pufe, Thomas</creatorcontrib><description>VEGF plays a role in bone remodeling. Ingrowth of reparative arterioles can be observed in late-stage osteonecrosis. To explore the reparative processes, we quantified the most important angiogenesis factor (VEGF) in different zones of late-stage glucocorticoid-induced osteonecrosis. We treated primary nonosteonecrosis osteoblasts with glucocorticoids in vitro as a model for the bone cells in early-stage steroid-related osteonecrosis. We obtained six late-stage (ARCO Stage IV) osteonecrosis femoral heads and six osteoarthritic femoral heads during THA. The expression of vascular endothelial growth factor was analyzed by reverse-transcription PCR, ELISA, or immunohistochemistry. Osteoblasts from the reactive interface (penumbra) of osteonecrosis femoral heads exhibited increased immunoreactivity to VEGF compared to those from the periphery. ELISA confirmed VEGF upregulation in the penumbra from osteonecrosis femoral heads. Primary osteoblasts derived from osteoarthritic femoral heads exhibited downregulation of VEGF after 24 hours of coincubation with glucocorticoids. The increase in VEGF in the reactive interface (penumbra) of osteonecrosis in late-stage femoral head may reflect a secondary phenomenon. The observed high amount of VEGF in later-stage osteonecrosis might stimulate the ingrowth of reparative arterioles into the femoral head.</description><identifier>ISSN: 0009-921X</identifier><identifier>EISSN: 1528-1132</identifier><identifier>DOI: 10.1007/s11999-009-1076-3</identifier><identifier>PMID: 19763724</identifier><language>eng</language><publisher>New York: Springer-Verlag</publisher><subject>Adult ; Cells, Cultured ; Conservative Orthopedics ; Dexamethasone - adverse effects ; Dose-Response Relationship, Drug ; Enzyme-Linked Immunosorbent Assay ; Femur Head - blood supply ; Femur Head - drug effects ; Femur Head - metabolism ; Femur Head - pathology ; Femur Head Necrosis - chemically induced ; Femur Head Necrosis - metabolism ; Femur Head Necrosis - pathology ; Femur Head Necrosis - physiopathology ; Glucocorticoids - adverse effects ; Humans ; Immunohistochemistry ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Neovascularization, Physiologic - drug effects ; Orthopedics ; Osteoarthritis, Hip - metabolism ; Osteoblasts - drug effects ; Osteoblasts - metabolism ; Osteoblasts - pathology ; Osteocytes - drug effects ; Osteocytes - metabolism ; Osteocytes - pathology ; Reverse Transcriptase Polymerase Chain Reaction ; Severity of Illness Index ; Sports Medicine ; Surgery ; Surgical Orthopedics ; Symposium: Tribute to Dr. Marshall Urist: Musculoskeletal Growth Factors ; Time Factors ; Up-Regulation ; Vascular Endothelial Growth Factor A - genetics ; Vascular Endothelial Growth Factor A - metabolism</subject><ispartof>Clinical orthopaedics and related research, 2009-12, Vol.467 (12), p.3273-3282</ispartof><rights>The Association of Bone and Joint Surgeons® 2009</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c534t-1ef6326a4358186fe4022037e62afd0d6865138fa05e1fa73e2323cfec38f20b3</citedby><cites>FETCH-LOGICAL-c534t-1ef6326a4358186fe4022037e62afd0d6865138fa05e1fa73e2323cfec38f20b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772917/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772917/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,41488,42557,51319,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19763724$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Varoga, Deike</creatorcontrib><creatorcontrib>Drescher, Wolf</creatorcontrib><creatorcontrib>Pufe, Melanie</creatorcontrib><creatorcontrib>Groth, Godo</creatorcontrib><creatorcontrib>Pufe, Thomas</creatorcontrib><title>Differential Expression of Vascular Endothelial Growth Factor in Glucocorticoid-related Osteonecrosis of the Femoral Head</title><title>Clinical orthopaedics and related research</title><addtitle>Clin Orthop Relat Res</addtitle><addtitle>Clin Orthop Relat Res</addtitle><description>VEGF plays a role in bone remodeling. Ingrowth of reparative arterioles can be observed in late-stage osteonecrosis. To explore the reparative processes, we quantified the most important angiogenesis factor (VEGF) in different zones of late-stage glucocorticoid-induced osteonecrosis. We treated primary nonosteonecrosis osteoblasts with glucocorticoids in vitro as a model for the bone cells in early-stage steroid-related osteonecrosis. We obtained six late-stage (ARCO Stage IV) osteonecrosis femoral heads and six osteoarthritic femoral heads during THA. The expression of vascular endothelial growth factor was analyzed by reverse-transcription PCR, ELISA, or immunohistochemistry. Osteoblasts from the reactive interface (penumbra) of osteonecrosis femoral heads exhibited increased immunoreactivity to VEGF compared to those from the periphery. ELISA confirmed VEGF upregulation in the penumbra from osteonecrosis femoral heads. Primary osteoblasts derived from osteoarthritic femoral heads exhibited downregulation of VEGF after 24 hours of coincubation with glucocorticoids. The increase in VEGF in the reactive interface (penumbra) of osteonecrosis in late-stage femoral head may reflect a secondary phenomenon. The observed high amount of VEGF in later-stage osteonecrosis might stimulate the ingrowth of reparative arterioles into the femoral head.</description><subject>Adult</subject><subject>Cells, Cultured</subject><subject>Conservative Orthopedics</subject><subject>Dexamethasone - adverse effects</subject><subject>Dose-Response Relationship, Drug</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Femur Head - blood supply</subject><subject>Femur Head - drug effects</subject><subject>Femur Head - metabolism</subject><subject>Femur Head - pathology</subject><subject>Femur Head Necrosis - chemically induced</subject><subject>Femur Head Necrosis - metabolism</subject><subject>Femur Head Necrosis - pathology</subject><subject>Femur Head Necrosis - physiopathology</subject><subject>Glucocorticoids - adverse effects</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Neovascularization, Physiologic - drug effects</subject><subject>Orthopedics</subject><subject>Osteoarthritis, Hip - metabolism</subject><subject>Osteoblasts - drug effects</subject><subject>Osteoblasts - metabolism</subject><subject>Osteoblasts - pathology</subject><subject>Osteocytes - drug effects</subject><subject>Osteocytes - metabolism</subject><subject>Osteocytes - pathology</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Severity of Illness Index</subject><subject>Sports Medicine</subject><subject>Surgery</subject><subject>Surgical Orthopedics</subject><subject>Symposium: Tribute to Dr. Marshall Urist: Musculoskeletal Growth Factors</subject><subject>Time Factors</subject><subject>Up-Regulation</subject><subject>Vascular Endothelial Growth Factor A - genetics</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><issn>0009-921X</issn><issn>1528-1132</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kUFv1DAQhS1U1C6FH8ClsnoP2J7ETi6VUNndIlXqBareLNcZd11l48V2Cv33ONpVCwdO1vi9-WZGj5CPnH3ijKnPifOu6yrGuoozJSt4Qxa8EW3FOYgjsmCz0gl-d0LepfRYSqgbcUxOeKckKFEvyPNX7xxGHLM3A13-3kVMyYeRBkdvTbLTYCJdjn3IGxxmyzqGX3lDV8bmEKkf6XqYbLAhZm-D76uIg8nY05uUMYxoY0g-zbQCoCvchlggV2j69-StM0PCD4f3lPxYLb9fXlXXN-tvl1-uK9tAnSuOToKQpoam5a10WDMhGCiUwrie9bKVDYfWGdYgd0YBChBgHdryKdg9nJKLPXc33W-xt-XUsoLeRb818VkH4_W_yug3-iE8aaGU6LgqgPMDIIafE6asH8MUx7KzFgCyqUGKYuJ703xwiuheBnCm57D0PixdItFzWBpKz9nfm712HNIpBrE3pCKNDxhfJ_-f-geWmaJB</recordid><startdate>20091201</startdate><enddate>20091201</enddate><creator>Varoga, Deike</creator><creator>Drescher, Wolf</creator><creator>Pufe, Melanie</creator><creator>Groth, Godo</creator><creator>Pufe, Thomas</creator><general>Springer-Verlag</general><general>Lippincott Williams &amp; Wilkins Ovid Technologies</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20091201</creationdate><title>Differential Expression of Vascular Endothelial Growth Factor in Glucocorticoid-related Osteonecrosis of the Femoral Head</title><author>Varoga, Deike ; Drescher, Wolf ; Pufe, Melanie ; Groth, Godo ; Pufe, Thomas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c534t-1ef6326a4358186fe4022037e62afd0d6865138fa05e1fa73e2323cfec38f20b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Cells, Cultured</topic><topic>Conservative Orthopedics</topic><topic>Dexamethasone - adverse effects</topic><topic>Dose-Response Relationship, Drug</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Femur Head - blood supply</topic><topic>Femur Head - drug effects</topic><topic>Femur Head - metabolism</topic><topic>Femur Head - pathology</topic><topic>Femur Head Necrosis - chemically induced</topic><topic>Femur Head Necrosis - metabolism</topic><topic>Femur Head Necrosis - pathology</topic><topic>Femur Head Necrosis - physiopathology</topic><topic>Glucocorticoids - adverse effects</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Neovascularization, Physiologic - drug effects</topic><topic>Orthopedics</topic><topic>Osteoarthritis, Hip - metabolism</topic><topic>Osteoblasts - drug effects</topic><topic>Osteoblasts - metabolism</topic><topic>Osteoblasts - pathology</topic><topic>Osteocytes - drug effects</topic><topic>Osteocytes - metabolism</topic><topic>Osteocytes - pathology</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Severity of Illness Index</topic><topic>Sports Medicine</topic><topic>Surgery</topic><topic>Surgical Orthopedics</topic><topic>Symposium: Tribute to Dr. Marshall Urist: Musculoskeletal Growth Factors</topic><topic>Time Factors</topic><topic>Up-Regulation</topic><topic>Vascular Endothelial Growth Factor A - genetics</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Varoga, Deike</creatorcontrib><creatorcontrib>Drescher, Wolf</creatorcontrib><creatorcontrib>Pufe, Melanie</creatorcontrib><creatorcontrib>Groth, Godo</creatorcontrib><creatorcontrib>Pufe, Thomas</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical orthopaedics and related research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Varoga, Deike</au><au>Drescher, Wolf</au><au>Pufe, Melanie</au><au>Groth, Godo</au><au>Pufe, Thomas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential Expression of Vascular Endothelial Growth Factor in Glucocorticoid-related Osteonecrosis of the Femoral Head</atitle><jtitle>Clinical orthopaedics and related research</jtitle><stitle>Clin Orthop Relat Res</stitle><addtitle>Clin Orthop Relat Res</addtitle><date>2009-12-01</date><risdate>2009</risdate><volume>467</volume><issue>12</issue><spage>3273</spage><epage>3282</epage><pages>3273-3282</pages><issn>0009-921X</issn><eissn>1528-1132</eissn><abstract>VEGF plays a role in bone remodeling. Ingrowth of reparative arterioles can be observed in late-stage osteonecrosis. To explore the reparative processes, we quantified the most important angiogenesis factor (VEGF) in different zones of late-stage glucocorticoid-induced osteonecrosis. We treated primary nonosteonecrosis osteoblasts with glucocorticoids in vitro as a model for the bone cells in early-stage steroid-related osteonecrosis. We obtained six late-stage (ARCO Stage IV) osteonecrosis femoral heads and six osteoarthritic femoral heads during THA. The expression of vascular endothelial growth factor was analyzed by reverse-transcription PCR, ELISA, or immunohistochemistry. Osteoblasts from the reactive interface (penumbra) of osteonecrosis femoral heads exhibited increased immunoreactivity to VEGF compared to those from the periphery. ELISA confirmed VEGF upregulation in the penumbra from osteonecrosis femoral heads. Primary osteoblasts derived from osteoarthritic femoral heads exhibited downregulation of VEGF after 24 hours of coincubation with glucocorticoids. The increase in VEGF in the reactive interface (penumbra) of osteonecrosis in late-stage femoral head may reflect a secondary phenomenon. The observed high amount of VEGF in later-stage osteonecrosis might stimulate the ingrowth of reparative arterioles into the femoral head.</abstract><cop>New York</cop><pub>Springer-Verlag</pub><pmid>19763724</pmid><doi>10.1007/s11999-009-1076-3</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-921X
ispartof Clinical orthopaedics and related research, 2009-12, Vol.467 (12), p.3273-3282
issn 0009-921X
1528-1132
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2772917
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; SpringerLink Journals - AutoHoldings
subjects Adult
Cells, Cultured
Conservative Orthopedics
Dexamethasone - adverse effects
Dose-Response Relationship, Drug
Enzyme-Linked Immunosorbent Assay
Femur Head - blood supply
Femur Head - drug effects
Femur Head - metabolism
Femur Head - pathology
Femur Head Necrosis - chemically induced
Femur Head Necrosis - metabolism
Femur Head Necrosis - pathology
Femur Head Necrosis - physiopathology
Glucocorticoids - adverse effects
Humans
Immunohistochemistry
Medicine
Medicine & Public Health
Middle Aged
Neovascularization, Physiologic - drug effects
Orthopedics
Osteoarthritis, Hip - metabolism
Osteoblasts - drug effects
Osteoblasts - metabolism
Osteoblasts - pathology
Osteocytes - drug effects
Osteocytes - metabolism
Osteocytes - pathology
Reverse Transcriptase Polymerase Chain Reaction
Severity of Illness Index
Sports Medicine
Surgery
Surgical Orthopedics
Symposium: Tribute to Dr. Marshall Urist: Musculoskeletal Growth Factors
Time Factors
Up-Regulation
Vascular Endothelial Growth Factor A - genetics
Vascular Endothelial Growth Factor A - metabolism
title Differential Expression of Vascular Endothelial Growth Factor in Glucocorticoid-related Osteonecrosis of the Femoral Head
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T02%3A16%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20Expression%20of%20Vascular%20Endothelial%20Growth%20Factor%20in%20Glucocorticoid-related%20Osteonecrosis%20of%20the%20Femoral%20Head&rft.jtitle=Clinical%20orthopaedics%20and%20related%20research&rft.au=Varoga,%20Deike&rft.date=2009-12-01&rft.volume=467&rft.issue=12&rft.spage=3273&rft.epage=3282&rft.pages=3273-3282&rft.issn=0009-921X&rft.eissn=1528-1132&rft_id=info:doi/10.1007/s11999-009-1076-3&rft_dat=%3Cproquest_pubme%3E2027497541%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=233654362&rft_id=info:pmid/19763724&rfr_iscdi=true